The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Acute ischaemic brain lesions in intracerebral haemorrhage: multicentre cross-sectional magnetic resonance imaging study
Open accessAbstract
Subclinical acute ischaemic lesions on brain magnetic resonance imaging have recently been described in spontaneous intracerebral haemorrhage, and may be important to understand pathophysiology and guide treatment. The underlying mechanisms are uncertain. We tested the hypothesis that ischaemic lesions are related to magnetic resonance imaging markers of the severity and type of small-vessel disease (hypertensive arteriopathy or cerebral amyloid angiopathy) in a multicentre, cross-sectional study. We studied consecutive patients with intracerebral haemorrhage from four specialist stroke centres, and age-matched stroke service referrals without intracerebral haemorrhage. Acute ischaemic lesions were assessed on magnetic resonance imaging (<3 months after intracerebral haemorrhage) using diffusion-weighted imaging. White matter changes and cerebral microbleeds were rated with validated scales. We investigated associations between diffusion-weighted imaging lesions, clinical and radiological characteristics. We included 114 patients with intracerebral haemorrhage (39 with clinically probable cerebral amyloid angiopathy) and 47 age-matched controls. The prevalence of diffusion-weighted imaging lesions was 9/39 (23%) in probable cerebral amyloid angiopathy-related intracerebral haemorrhage versus 6/75 (8%) in the remaining patients with intracerebral haemorrhage (P = 0.024); no diffusion-weighted imaging lesions were found in controls. Diffusion-weighted imaging lesions were mainly cortical and were associated with mean white matter change score (odds ratio 1.14 per unit increase, 95% confidence interval 1.02-1.28, P = 0.024) and the presence of strictly lobar cerebral microbleeds (odds ratio 3.85, 95% confidence interval 1.15-12.93, P = 0.029). Acute, subclinical ischaemic brain lesions are frequent but previously underestimated after intracerebral haemorrhage, and are three times more common in cerebral amyloid angiopathy-related intracerebral haemorrhage than in other intracerebral haemorrhage types. Ischaemic brain lesions are associated with white matter changes and cerebral microbleeds, suggesting that they result from an occlusive small-vessel arteriopathy. Diffusion-weighted imaging lesions contribute to the overall burden of vascular-related brain damage in intracerebral haemorrhage, and may be a useful surrogate marker of ongoing ischaemic injury from small-vessel damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria
Knudsen, K. A., Rosand, J., Karluk, D., & Greenberg, S. M. (2001) · Neurology · doi:10.1212/wnl.56.4.537 · Cited by 1,015
Review: sporadic cerebral amyloid angiopathy
Attems, J., Jellinger, K., Thal, D. R., & Van Nostrand, W. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01137.x · Cited by 371
Warfarin-associated hemorrhage and cerebral amyloid angiopathy: A genetic and pathologic study
Rosand, J., Hylek, E. M., O’Donnell, H. C., & Greenberg, S. M. (2000) · Neurology · doi:10.1212/wnl.55.7.947 · Cited by 305 · cited 1×
“Although the risk of anti-coagulation likely overweighs the benefit in most patients with intracerebral haemorrhage due to CAA, the risk versus benefit of anti-platelet agents is less clear (Rosand et al., 2000; Biffi et al., 2010).”
Backgroundβ-Amyloid, Blood Vessels, and Brain Function
Smith, E. E., & Greenberg, S. M. (2009) · Stroke · doi:10.1161/strokeaha.108.536839 · Cited by 293
Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms
Attems, J. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1074-9 · Cited by 242
Jouvent (2011) · doi:10.1161/strokeaha.110.594218 · Cited by 86
Cited by
The overlap between vascular disease and Alzheimer’s disease - lessons from pathology
Attems, J., & Jellinger, K. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0206-2 · Cited by 739
“Of note, the majority of cases with CAA-related ICH had hypertension, suggesting that hypertension is an important additional causal factor in CAA-related ICHs [95,96].”
BackgroundCharidimou, A., Gang, Q., & Werring, D. J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301308 · Cited by 611
“In a recent multicentre cohort of patients with spontaneous ICH, we found that the prevalence of hypertension in CAA related ICH was 62%dsignificantly less than in non-CAA related ICH (85%).(35) Whether hypertension in association with CAA confers a greater risk for ICH compared with CAA alone is an important clinical…”
BackgroundInfluentialSelf-citationDiagnosis of Cerebral Amyloid Angiopathy: Evolution of the Boston Criteria
Greenberg, S. M., & Charidimou, A. (2018) · Stroke · doi:10.1161/strokeaha.117.016990 · Cited by 439
Self-citationDaulatzai, M. A. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23777 · Cited by 429
Charidimou, A., Linn, J., Vernooij, M. W., Opherk, C., Akoudad, S., Baron, J.-C., Greenberg, S. M., Jäger, H. R., & Werring, D. J. (2015) · Brain · doi:10.1093/brain/awv162 · Cited by 385
Self-citationCerebral Amyloid Angiopathy: Emerging Concepts
Yamada, M. (2015) · Journal of Stroke · doi:10.5853/jos.2015.17.1.17 · Cited by 367
Detection, risk factors, and functional consequences of cerebral microinfarcts
van Veluw, S. J., Shih, A. Y., Smith, E. E., Chen, C., Schneider, J. A., Wardlaw, J. M., Greenberg, S. M., & Biessels, G. J. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30196-5 · Cited by 303
Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy
Reijmer, Y. D., Fotiadis, P., Martinez-Ramirez, S., Salat, D. H., Schultz, A., Shoamanesh, A., Ayres, A. M., Vashkevich, A., Rosas, D., Schwab, K., et al. (2015) · Brain · doi:10.1093/brain/awu316 · Cited by 181
Thal, D. R., Attems, J., & Ewers, M. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141461 · Cited by 100
Increased Number of Microinfarcts in Alzheimer Disease at 7-T MR Imaging
van Rooden, S., Goos, J. D. C., van Opstal, A. M., Versluis, M. J., Webb, A. G., Blauw, G. J., van der Flier, W. M., Scheltens, P., Barkhof, F., van Buchem, M. A., et al. (2014) · Radiology · doi:10.1148/radiol.13130743 · Cited by 86
Estimating Total Cerebral Microinfarct Burden From Diffusion-Weighted Imaging
Auriel, E., Westover, M. B., Bianchi, M. T., Reijmer, Y., Martinez-Ramirez, S., Ni, J., Van Etten, E., Frosch, M. P., Fotiadis, P., Schwab, K., et al. (2015) · Stroke · doi:10.1161/strokeaha.115.009208 · Cited by 61
Al-Shawi, R., Tennent, G. A., Millar, D. J., Richard-Londt, A., Brandner, S., Werring, D. J., Simons, J. P., & Pepys, M. B. (2016) · Open Biology · doi:10.1098/rsob.150202 · Cited by 26
Self-citationMcNally, J. S., Sakata, A., Alexander, M. D., Dewitt, L. D., Sonnen, J. A., Menacho, S. T., Stoddard, G. J., Kim, S.-E., & de Havenon, A. H. (2021) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7047 · Cited by 18
Inflammation in Cerebral Amyloid Angiopathy‐Related Transient Focal Neurological Episodes
Sellimi, A., Panteleienko, L., Mallon, D., Fandler‐Höfler, S., Oliver, R., Harvey, V., Zandi, M. S., Banerjee, G., & Werring, D. J. (2025) · Annals of Neurology · doi:10.1002/ana.27164 · Cited by 17
Self-citation
Metadata
- Authors
- Gregoire, S. M., Charidimou, A., Gadapa, N., Dolan, E., Antoun, N., Peeters, A., Vandermeeren, Y., Laloux, P., Baron, J.-C., Jäger, H. R., & Werring, D. J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-08
- Volume
- 134
- Issue
- 8
- Pages
- 2376-2386
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2123199210
- Cited by
- 185
- References
- 7
- FWCI
- 8.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.